Standard
FDA Clears Biometric Tool Neurora to Assist Clinicians in Autism Evaluations
Federal regulators have cleared a new technological tool designed to assist healthcare professionals in identifying autism in young children, offering a fresh resource for clinicians navigating complex diagnostic assessments. The Food and Drug Administration cleared Neurora this month to help inform diagnostic decisions for children ranging from 18 months to 12 years old. Developed by…
